Details

Last Funding Type

Series B

Last Funding Money Raised

$8M

Industries

Biotechnology,Health Care,Medical Device

Founded date

Jan 1, 2010

Number Of Employee

11 - 50

Operating Status

Active

Vyome Biosciences is an innovation driven company, with a vision to
develop novel drugs for antibiotics-resistant acne and other opportunist
pathogens through a unique pipeline of antibiotics that retard resistance
development.

Vyome Biosciences’ management team members are the leaders in the field,
with deep expertise, demonstrated capability and a proven track record of
successfully launching over 50 products in dermatology & other life
sciences areas, and building visionary companies.

Vyome’s development platform is completely risk mitigated. Vyome has a deep
pipeline of IP based products targeting multiple indications. The *lead
molecule (VB 1953)*, which targets the huge unmet need in the drug
resistant acne prescription market, will be entering the clinical phase
with *USFDA IND Application Filing in Q4 2015*.

Vyome has state-of-the-art infrastructure facilities to carry out all its
research and lab development work, with full-fledged formulation,
analytical, chemistry, biology & molecular biology, clinical and the
regulatory divisions. The infrastructure and the team enables Vyome to
conceive ideas, develop them and commercialize them at a rapid pace.